Tom Hu, MD
Assistant Professor of Clinical Pathology and Laboratory Medicine
Perelman School of Medicine at the University of Pennsylvania
Contact InformationHospital of the University of Pennsylvania
3400 Spruce Street
6 Founders Pavilion – Room 6.095D
Philadelphia, , 19104
Office: 2484203289
Email: tom.hu@pennmedicine.upenn.edu
Specialty Division
Anatomic Pathology
Education
BS (Neuroscience), University of Michigan - Ann Arbor, 2012
MD Wayne State University, 2016
Specialty Certification
Anatomic and Clinical Pathology - American Board of Pathology, 2020
Cytopathology - American Board of Pathology, 2021
Postgraduate Training
Resident in Anatomic and Clinical Pathology, Hospital of University of Pennsylvania, 2016-2020
Fellow in Cytopathology, Hospital of University of Pennsylvania, 2020-2021
Awards and Honors
Kevin E. Salhany, MD Award for Excellence in Clinical Pathology Teaching of the University of Pennsylvania, 2023
James E. Wheeler, M.D. Award for Excellence in Anatomic Pathology Resident Training of the University of Pennsylvania, 2024
Memberships and Professional Organizations
College of American Pathologists, 2016 - Present
United State and Canadian Academy of Pathology, 2016 - Present
American Society for Clinical Pathology, 2016 - Present
American Society of Cytopathology, 2018 - Present
International Society of Breast Pathology, 2019 - Present
Web Links
Selected Publications
Cystic Neutrophilic Granulomatous Mastitis: Imaging Features with Histopathologic Correlation
Joseph Villavicencio, Tom Hu, Sophia O'Brien, Samantha Zuckerman, Journal of Breast Imaging, 2024
Impact of oviductal versus ovarian epithelial cell of origin on ovarian endometrioid carcinoma phenotype in the mouse
Wu R, Zhai Y, Kuick R, Karnezis AN, Garcia P, Naseem A, Hu TC, Fearon ER, Cho KR, The Journal of Pathology 240(3): 341-351, 2016
Type I to Type II Ovarian Carcinoma Progression: Mutant Trp53 or Pik3ca Confers a More Aggressive Tumor Phenotype in a Mouse Model of Ovarian Cancer
Wu R, Baker S, Hu T, Norman K, Fearon E, Cho K, American Journal of Pathology 182(4): 1391-9, 2013
Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma
Wu R, Hu T, Rehemtulla A, Fearon E, Cho K, Clinical Cancer Research 17(23): 7359-7372, 2011
